Form 4: Opus Genetics Director Reports Stock Transaction
Insider Transaction (Form 4)
Cam Gallagher, a Director of Opus Genetics, Inc., reported multiple transactions in common stock on September 8, 2026.
Summary
- Option exercise/conversion: acquired 784,314 Common Stock at $1.15 ($901,961) on September 8, 2026; holds 2,800,111 after (Direct).
- Option exercise/conversion: disposed of 784,314 Warrant (right to buy) on September 8, 2026 (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Cam Gallagher — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-08 | Option exercise/conversion | Common Stock | 784,314 | $1 | $902.0K | 2,800,111 |
| 2026-09-08 | Option exercise/conversion | Warrant (right to buy) | 784,314 | — | — | 0 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-08 | Option exercise/conversion (784,314 shares) |
| 2026-09-08 | Option exercise/conversion (784,314 shares) |
Keywords
insider transaction, Form 4, IRD, Opus Genetics, Inc., neutral, Cam Gallagher
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.